Analyze Diet

Topic:Pharmacokinetics

Pharmacokinetics in horses involves the study of how drugs are absorbed, distributed, metabolized, and excreted in equine species. This field of study provides insights into the time course of drug concentrations within the horse's body and helps in understanding the effects of various pharmaceuticals. Key parameters in equine pharmacokinetics include absorption rates, bioavailability, half-life, and clearance. These parameters can vary significantly due to factors such as age, breed, and health status of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacokinetic profiles of different drugs in horses, aiming to optimize dosing regimens and improve therapeutic outcomes in equine medicine.
Optimizing human in vivo dosing and delivery of β-alanine supplements for muscle carnosine synthesis.
Amino acids    February 23, 2012   Volume 43, Issue 1 57-65 doi: 10.1007/s00726-012-1245-7
Stellingwerff T, Decombaz J, Harris RC, Boesch C.Interest into the effects of carnosine on cellular metabolism is rapidly expanding. The first study to demonstrate in humans that chronic β-alanine (BA) supplementation (~3-6 g BA/day for ~4 weeks) can result in significantly augmented muscle carnosine concentrations (>50%) was only recently published. BA supplementation is potentially poised for application beyond the niche exercise and performance-enhancement field and into other more clinical populations. When examining all BA supplementation studies that directly measure muscle carnosine (n=8), there is a significant linear correlation...
Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse.
Journal of veterinary pharmacology and therapeutics    February 20, 2012   Volume 36, Issue 1 21-30 doi: 10.1111/j.1365-2885.2012.01385.x
Knych HK, Casbeer HC, McKemie DS, Arthur RM.Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exer...
Analgesic and anti-hyperalgesic effects of epidural morphine in an equine LPS-induced acute synovitis model.
Veterinary journal (London, England : 1997)    February 17, 2012   Volume 193, Issue 2 464-470 doi: 10.1016/j.tvjl.2012.01.015
van Loon JP, Menke ES, L'ami JJ, Jonckheer-Sheehy VS, Back W, René van Weeren P.Epidural morphine is widely used in veterinary medicine, but there is no information about the anti-hyperalgesic and anti-inflammatory effects in acute inflammatory joint disease in horses. The analgesic, anti-hyperalgesic and anti-inflammatory effects of epidural morphine (100mg/animal or 0.17 ± 0.02 mg/kg) were therefore investigated in horses with acute synovitis. In a cross-over study, synovitis was induced in the talocrural joint by intra-articular lipopolysaccharide (LPS). The effect of epidural morphine was evaluated using physiological, kinematic and behavioural variables. Ranges of m...
The use of phenytoin in two horses following conversion from atrial fibrillation.
New Zealand veterinary journal    February 15, 2012   Volume 60, Issue 3 210-212 doi: 10.1080/00480169.2011.643751
Dicken M, Gordon SJ, Mayhew IG.No abstract available
Regulatory control of glycopyrrolate in performance horses using validated UHPLC/MS-MS methods.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    February 13, 2012   Volume 889-890 130-137 doi: 10.1016/j.jchromb.2012.02.008
Rumpler MJ, Sams RA, Colahan P.We describe a validated, rapid, sensitive, and specific UHPLC-MS/MS method to detect and quantify glycopyrrolate in 0.5 mL of horse urine. Further, we investigated the elimination of glycopyrrolate in urine after both intravenous and oral administration of clinically relevant doses to Thoroughbred horses. Quantification was performed by weighted, linear regression analysis using a deuterated analogue of glycopyrrolate as internal standard (IS). The method was characterized by a linear range of 5-2500 pg/mL, a lower limit of quantification of 5 pg/mL and a limit of detection of 1 pg/mL. The int...
Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza.
Veterinary journal (London, England : 1997)    February 10, 2012   Volume 193, Issue 2 358-362 doi: 10.1016/j.tvjl.2012.01.005
Yamanaka T, Bannai H, Nemoto M, Tsujimura K, Kondo T, Muranaka M, Hobo S, Minamijima YH, Yamada M, Matsumura T.Equine influenza A virus (EIV) of the H3N8 subtype is an important pathogen causing acute respiratory disease in horses. Peramivir is a selective inhibitor of the influenza virus neuraminidase (NA). The characteristics of peramivir are not only its capacity for parenteral administration, but also its strong affinity for NA and slow off-rate from the NA-peramivir complex, suggesting that it could lead to a prolonged inhibitory effect and thus allow a lower dosing frequency. The aims of this study were to evaluate the inhibitory efficacy of peramivir against the NA activities of EIV in vitro and...
Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
American journal of veterinary research    January 28, 2012   Volume 73, Issue 2 290-295 doi: 10.2460/ajvr.73.2.290
Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR.To characterize the bioavailability and pharmacokinetics of oral and injectable formulations of methadone after IV, oral, and intragastric administration in horses. Methods: 6 healthy adult horses. Methods: Horses received single doses (each 0.15 mg/kg) of an oral formulation of methadone hydrochloride orally or intragastrically or an injectable formulation of the drug orally, intragastrically, or IV (5 experimental treatments/horse; 2-week washout period between each experimental treatment). A blood sample was collected from each horse before and at predetermined time points over a 360-minute...
Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
Journal of veterinary pharmacology and therapeutics    January 11, 2012   Volume 35, Issue 6 615-617 doi: 10.1111/j.1365-2885.2011.01362.x
Cox S, Dudenbostel L, Sommardahl C, Yarbrough J, Saleh M, Doherty T.No abstract available
Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Journal of veterinary pharmacology and therapeutics    January 11, 2012   Volume 35, Issue 5 478-488 doi: 10.1111/j.1365-2885.2011.01347.x
Wojtasiak-Wypart M, Soma LR, Rudy JA, Uboh CE, Boston RC, Driessen B.Romifidine HCl (romifidine) is an α(2)-agonist commonly used in horses. This study was undertaken to investigate the pharmacokinetics (PK) of romifidine following intravenous (i.v.) administration and describe the relationship between PK parameters and simultaneously recorded pharmacodynamic (PD) parameters. Romifidine (80 μg/kg) was administered by i.v. infusion over 2 min to six adult Thoroughbred horses, and plasma samples were collected and analyzed using liquid chromatography-mass spectrometry. Limit of quantification was <0.1 ng/mL. PD parameters and arterial blood gases were measur...
Daily endogenous cortisol production and hydrocortisone pharmacokinetics in adult horses and neonatal foals.
American journal of veterinary research    December 30, 2011   Volume 73, Issue 1 68-75 doi: 10.2460/ajvr.73.1.68
Hart KA, Dirikolu L, Ferguson DC, Norton NA, Barton MH.To compare daily endogenous cortisol production rate and the pharmacokinetics of an i.v. bolus of hydrocortisone between neonatal foals and adult horses. Methods: 10 healthy full-term 2- to 4-day-old foals and 7 healthy adult horses. Methods: Blood samples were collected from each horse every 15 to 20 minutes for 24 hours for determination of 24-hour mean cortisol concentration. Afterward, dexamethasone (0.08 mg/kg) was administered i.v. to suppress endogenous cortisol production. Twelve hours afterward, hydrocortisone sodium succinate (1.0 mg/kg) was administered as a rapid i.v. bolus and ser...
Use of furosemide for exercise-induced pulmonary hemorrhage in racehorses.
Journal of the American Veterinary Medical Association    December 27, 2011   Volume 239, Issue 11 1407 
Hinchcliff KW, Morley PS, Guthrie A.No abstract available
Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals.
Drug metabolism and disposition: the biological fate of chemicals    December 14, 2011   Volume 40, Issue 3 522-528 doi: 10.1124/dmd.111.042267
Peters J, Eggers K, Oswald S, Block W, Lütjohann D, Lämmer M, Venner M, Siegmund W.Pulmonary penetration of clarithromycin (CLR) in epithelial lining fluid (ELF) and bronchoalveolar lavage cells (BALCs) can be influenced by CYP3A4, by P-glycoprotein, and, according to our hypothesis, by a member of the organic anion-transporting protein (OATP) family, for which rifampicin (RIF) is inhibiting in single doses but inducing after long-term coadministration. To assess the partial inhibitory effect, we measured absorption and pulmonary distribution of CLR after short-term (2.5-day) coadministration of RIF, after which up-regulation is not expected. The drug interaction study was p...
Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses.
Veterinary anaesthesia and analgesia    December 14, 2011   Volume 39, Issue 1 12-20 doi: 10.1111/j.1467-2995.2011.00681.x
Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.To determine constant rate infusion (CRI) protocols for romifidine (R) and romifidine combined with butorphanol (RB) resulting in constant sedation and romifidine plasma concentrations. Methods: Blinded randomized crossover study. Methods: Ten adult research horses. Methods: Part I: After determining normal height of head above ground (HHAG = 100%), loading doses of romifidine (80 μg kg(-1)) with butorphanol (RB: 18 μg kg(-1)) or saline (R) were given intravenously (IV). Immediately afterwards, a butorphanol (RB: 25 μg kg(-1) hour(-1)) or saline (R) CRI was administered for 2 hours. The HHA...
[Use of local anaesthetics in the horse. Pharmacological and legal aspects].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 6, 2011   Volume 39, Issue 2 117-123 
Kästner S.No abstract available
Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses.
Journal of veterinary pharmacology and therapeutics    December 5, 2011   Volume 35, Issue 6 541-549 doi: 10.1111/j.1365-2885.2011.01351.x
Leclere M, Magdesian KG, Cole CA, Szabo NJ, Ruby RE, Rhodes DM, Edman J, Vale A, Wilson WD, Tell LA.Azithromycin is widely used in foals but has not been studied in adult horses. The goals of this study were to determine the pharmacokinetic profile and to make a preliminary assessment of the safety of azithromycin in adult horses. Azithromycin was administered intravenously (5 mg/kg) and intragastrically (10 mg/kg) to six healthy mares in a crossover design. Serial plasma samples, blood neutrophils, and pulmonary macrophages were collected for the measurement of azithromycin concentrations. Azithromycin was also administered orally (10 mg/kg) once a day for 5 days to five healthy mares for p...
Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Journal of veterinary pharmacology and therapeutics    December 2, 2011   Volume 35, Issue 4 413-416 doi: 10.1111/j.1365-2885.2011.01356.x
Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG.No abstract available
Anesthetic induction with guaifenesin and propofol in adult horses.
American journal of veterinary research    December 1, 2011   Volume 72, Issue 12 1569-1575 doi: 10.2460/ajvr.72.12.1569
Brosnan RJ, Steffey EP, Escobar A, Palazoglu M, Fiehn O.To evaluate whether guaifenesin can prevent adverse anesthetic induction events caused by propofol and whether a guaifenesin-propofol induction combination has brief cardiovascular effects commensurate with rapid drug washout. Methods: 8 healthy adult horses. Methods: Guaifenesin was administered IV for 3 minutes followed by IV injection of a bolus of propofol (2 mg/kg). Additional propofol was administered if purposeful movement was detected. Anesthesia was maintained for 2 hours with isoflurane or sevoflurane at 1.2 times the minimum alveolar concentration with controlled normocapnic ventila...
Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
Veterinary anaesthesia and analgesia    November 25, 2011   Volume 39, Issue 1 119-120 doi: 10.1111/j.1467-2995.2011.00683.x
Gurney M, Mosing M.No abstract available
Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses.
Veterinary anaesthesia and analgesia    November 22, 2011   Volume 39, Issue 1 1-11 doi: 10.1111/j.1467-2995.2011.00653.x
Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.To elaborate constant rate infusion (CRI) protocols for xylazine (X) and xylazine/butorphanol (XB) which will result in constant sedation and steady xylazine plasma concentrations. Methods: Blinded randomized experimental study. Methods: Ten adult research horses. Methods: Part I: After normal height of head above ground (HHAG = 100%) was determined, a loading dose of xylazine (1 mg kg(-1) ) with butorphanol (XB: 18 μg kg(-1) ) or saline (X: equal volume) was given slowly intravenously (IV). Immediately afterwards, a CRI of butorphanol (XB: 25 μg kg(-1) hour(-1)) or saline (X) was administer...
Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse.
Veterinary anaesthesia and analgesia    November 22, 2011   Volume 39, Issue 1 38-48 doi: 10.1111/j.1467-2995.2011.00669.x
Grimsrud KN, Mama KR, Steffey EP, Stanley SD.To describe the pharmacodynamics and pharmacokinetics following an intravenous (IV) bolus dose of medetomidine in the horse. Methods: Prospective experimental trial. Methods: Eight, mature healthy horses age 11.7 ± 4.6 (mean ± SD) years, weighing 557 ± 54 kg. Methods: Medetomidine (10 μg kg(-1) ) was administered IV. Blood was sampled at fixed time points from before drug administration to 48 hours post administration. Behavioral, physiological and biochemical data were obtained at predetermined time points from 0 minutes to 24 hours post administration. An algometer was also used to measu...
Pharmacokinetic assessment of ketanserin in the horse.
Journal of veterinary pharmacology and therapeutics    November 18, 2011   Volume 35, Issue 5 472-477 doi: 10.1111/j.1365-2885.2011.01346.x
Aljuffali IA, Brainard BM, Moore JN, Kwon S, Allen D, Robertson TP, Arnold RD.The purpose of this study was to determine the pharmacokinetics (PK) of the 5-HT(2A) receptor antagonist ketanserin in healthy adult horses, and to develop a computational model that could be used to optimize dosing. Plasma concentrations of ketanserin were determined using liquid chromatography with mass spectrometry after single and multiple intravenous administration in the horse. A two-compartment linear pharmacokinetic model described the plasma concentration-time profile of ketanserin after single and multiple doses in healthy horses; the terminal half-life was 11.5 h; steady-state volum...
Validation of a liquid chromatography-tandem mass spectrometry method for quantification of glycopyrrolate in horse plasma.
Journal of analytical toxicology    November 15, 2011   Volume 35, Issue 9 656-664 doi: 10.1093/anatox/35.9.656
Rumpler MJ, Sams RA, Colahan P.A rapid, sensitive, and specific ultra-high-performance liquid chromatography with heated electrospray ionization-tandem mass spectrometry (UHPLC-HESI-MS-MS) method to detect and quantify glycopyrrolate in horse plasma has been developed and validated. We also determined glycopyrrolate in plasma after oral and intravenous administration of clinically relevant doses to Thoroughbred horses. Calibration was accomplished by weighted, linear regression analysis using a deuterated analogue of glycopyrrolate as internal standard (IS). Glycopyrrolate (GLY) and the IS (GLY-d(3)) were isolated from plas...
In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.
Schweizer Archiv fur Tierheilkunde    November 3, 2011   Volume 153, Issue 11 509-513 doi: 10.1024/0036-7281/a000262
Müller JM, Wissemann J, Meli ML, Dasen G, Lutz H, Heinzerling L, Feige K.Whole blood pharmacokinetics of intratumourally injected naked plasmid DNA coding for equine Interleukin 12 (IL-12) was assessed as a means of in vivo gene transfer in the treatment of melanoma in grey horses. The expression of induced interferon gamma (IFN-g) was evaluated in order to determine the pharmacodynamic properties of in vivo gene transduction. Seven grey horses bearing melanoma were injected intratumourally with 250 µg naked plasmid DNA coding for IL-12. Peripheral blood and biopsies from the injection site were taken at 13 time points until day 14 post injection (p.i.). Samples w...
Macrocyclic lactones for parasite control in equids.
Current pharmaceutical biotechnology    November 2, 2011   Volume 13, Issue 6 1070-1077 doi: 10.2174/138920112800399310
Lyons ET, Tolliver SC.Macrocyclic lactones (MLs) revolutionized parasite control in horses and other animals. They are unique in that they are effective against arthropods and nematodes. The first of the widely used avermectins was ivermectin. In 1983, it was marketed for use in horses as an injectable formulation but was withdrawn in 1984 after about a year and half on the market because of adverse problems. It was replaced by a paste formulation and an oral/stomach tube liquid formulation. Ivermectin is highly active on bots, ascarids, large and small strongyles, pinworms, strongyloides, stomach worms, and some o...
Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
American journal of veterinary research    October 26, 2011   Volume 72, Issue 11 1505-1513 doi: 10.2460/ajvr.72.11.1505
Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M.To identify and characterize cytochrome P450 enzymes (CYPs) responsible for the metabolism of racemic ketamine in 3 mammalian species in vitro by use of chemical inhibitors and antibodies. Methods: Human, canine, and equine liver microsomes and human single CYP3A4 and CYP2C9 and their canine orthologs. Methods: Chemical inhibitors selective for human CYP enzymes and anti-CYP antibodies were incubated with racemic ketamine and liver microsomes or specific CYPs. Ketamine N-demethylation to norketamine was determined via enantioselective capillary electrophoresis. Results: The general CYP inhibit...
Statistical and biological considerations in evaluating drug efficacy in equine strongyle parasites using fecal egg count data.
Veterinary parasitology    October 18, 2011   Volume 185, Issue 1 45-56 doi: 10.1016/j.vetpar.2011.10.011
Vidyashankar AN, Hanlon BM, Kaplan RM.Anthelmintic resistance (AR) is a serious problem for the control of equine gastrointestinal nematodes, particularly in the cyathostomins. The fecal egg count reduction test (FECRT) is the most common method for diagnosing AR and serves as the practical gold standard. However, accurate quantification of resistance and especially accurate diagnosis of emerging resistance to avermectin/milbemycin (A/M) drugs, is hampered by a lack of accepted standards for study design, data analysis, and data interpretation. In order to develop rational evidence-based standards for diagnosis of resistance, one ...
Effects of a constant rate infusion of detomidine on cardiovascular function, isoflurane requirements and recovery quality in horses.
Veterinary anaesthesia and analgesia    October 13, 2011   Volume 38, Issue 6 544-554 doi: 10.1111/j.1467-2995.2011.00659.x
Schauvliege S, Marcilla MG, Verryken K, Duchateau L, Devisscher L, Gasthuys F.To examine the influence of a detomidine constant rate infusion (CRI) on cardiovascular function, isoflurane requirements and recovery quality in horses undergoing elective surgery. Methods: Prospective, randomized, blinded, clinical trial. Methods: Twenty adult healthy horses. Methods: After sedation (detomidine, 10 μg kg(-1) intravenously [IV]) and induction of anaesthesia (midazolam 0.06 mg kg(-1) , ketamine 2.2 mg kg(-1) IV), anaesthesia was maintained with isoflurane in oxygen/air (inspiratory oxygen fraction 55%). When indicated, the lungs were mechanically ventilated. Dobut...
Quantitative analysis of a quaternary ammonium drug: ipratropium bromide by LC/ESI-MS(n) in horse plasma and urine.
Biomedical chromatography : BMC    October 12, 2011   Volume 26, Issue 4 534-540 doi: 10.1002/bmc.1701
Garcia P, Paris AC, Leufroy A, Popot MA, Bonnaire Y.A quantitative method, using LC/ESI-MS(n) with a quadrupole linear ion trap mass analyzer, has been developed for the analysis of ipratropium cation in horse plasma and urine. The method applies solid-phase extraction with WCX cartridges for plasma and MM2 cartridges for urine, prior to analysis by LC/ESI-MS(n). The efficiency of extraction combined with the sensitivity and the selectivity of MS(n) allows for the quantification of ipratropium cation at picogram per milliliter levels. The analytical capabilities of the method have been successfully checked by the quantitative analysis of ipratr...
Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
American journal of veterinary research    October 4, 2011   Volume 72, Issue 10 1378-1385 doi: 10.2460/ajvr.72.10.1378
Dimaio Knych HK, Stanley SD.To characterize pharmacokinetics and pharmacodynamics of detomidine gel administered sublingually in accordance with label instructions to establish appropriate withdrawal guidelines for horses before competition. Methods: 12 adult racehorses. Methods: Horses received a single sublingual administration of 0.04 mg of detomidine/kg. Blood samples were collected before and up to 72 hours after drug administration. Urine samples were collected for 5 days after detomidine administration. Plasma and urine samples were analyzed via liquid chromatography-mass spectrometry, and resulting data were anal...
Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
Equine veterinary journal    September 25, 2011   Volume 44, Issue 4 453-458 doi: 10.1111/j.2042-3306.2011.00459.x
Schnabel LV, Papich MG, Divers TJ, Altier C, Aprea MS, McCarrel TM, Fortier LA.Minocycline holds great potential for use in horses not only for its antimicrobial effects but also for its anti-inflammatory and neuroprotective properties. However, there are no pharmacokinetic or safety data available regarding the use of oral minocycline in horses. Objective: To determine pharmacokinetics, safety and penetration into plasma, synovial fluid, aqueous humour (AH) and cerebral spinal fluid (CSF) of minocycline after oral administration of multiple doses in horses and to determine the minimum inhibitory concentrations (MIC) of minocycline for equine pathogenic bacteria. Methods...
1 30 31 32 33 34 97